報(bào)告題目： Cognitive Assessment in the Framingham Heart Study: Purpose, Implementation, Critical Considerations
報(bào)告人：Ryan Piers 研究助理
單位：波士頓大學(xué)
報(bào)告時(shí)間：2017年6月21日 (周三) 下午3:30 – 5:30
報(bào)告地點(diǎn)：逸夫樓508會(huì)議室
報(bào)告摘要: Neuropsychological testing is the gold standard for diagnosis of neurodegenerative disorders such as Alzheimer’s disease (AD). Within the Framingham Heart Study, a longitudinal research institution in the United States, the Boston Process Approach (BPA) has been shown to amplify the role of neuropsychology in the study of preclinical and clinical AD. Furthermore, the addition of digital technology has enhanced the sensitivity of BPA to detect insidious onset changes even earlier than had been previously possible. Recent developments may alter the ways in which cognitive function will be assessed going forward.
報(bào)告人簡介: Ryan Piers is a research assistant in clinical psychology at Boston University. He has been involved in cognitive and neurological research at the Framingham Heart Study (FHS) since 2013. He currently oversees the quality control of all digital and traditional neuropsychological testing at FHS and advises on the programming of a cognitive test platform being built in collaboration with researchers at Tsinghua University. Mr. Piers’ research interests include preclinical and clinical Alzheimer’s disease, digital cognitive assessment, vascular brain aging, mental health, and ApoE4.
太陽集團(tuán)tyc5997
TOP
